Monographie - Reteplase

Reteplase

Kauppanimi

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Retavase

Yhdysvallat

Viitteet : Reteplase

	tyyppi	julkaisu
1713	Lehti	Trissel LA, Saenz CA. Compatibility screening of bivalirudin during simulated Y-site administration with other drugs. Int J Pharm Compound 2002 ; 6: 311-315.
2212	Laboratorio	Reteplase (Rapilysin®) - Summary of Product Characteristics Actavis UK Ltd 2015
3539	Laboratorio	Bivalirudin (Angiox®) - Summary of Product Characteristics. The Medecines Company 2013
3540	Laboratorio	Heparin sodium - Summary of Product Characteristics. Wockhardt 2010